Recently, a study showed that SATB1 overexpression is an independent factor for overall survival (OS) and progression-free survival (PFS) in patients with diffuse large B cell lymphoma (DLBCL) [16]. This evidence concerns the gene SATB1 and diffuse large B-cell lymphoma.